{
  "ticker": "AUPH",
  "company_name": "Aurinia Pharmaceuticals Inc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01586845",
      "title": "Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Renal Transplantation",
      "start_date": "2013-03",
      "completion_date": "2015-12",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT04147650",
      "title": "Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Dry Eye Syndrome, Keratoconjunctivitis Sicca",
      "start_date": "2019-10-14",
      "completion_date": "2020-10-08",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03598036",
      "title": "Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Focal Segmental Glomerulosclerosis",
      "start_date": "2018-06-21",
      "completion_date": "2020-05-19",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03597139",
      "title": "Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis\u00ae in Subjects With Dry Eye Disease",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Dry Eye",
      "start_date": "2018-08-13",
      "completion_date": "2018-12-13",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03021499",
      "title": "Aurinia Renal Response in Active Lupus With Voclosporin",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Lupus Nephritis",
      "start_date": "2017-05-17",
      "completion_date": "2019-10-10",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT00408187",
      "title": "Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Psoriasis",
      "start_date": "2006-12",
      "completion_date": "2008-12",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT02949973",
      "title": "Aurinia Early Urinary Protein Reduction Predicts Response",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Lupus Nephritis",
      "start_date": "2015-06",
      "completion_date": "2017-02-17",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05306379",
      "title": "Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Drug-drug Interaction",
      "start_date": "2022-01-24",
      "completion_date": "2022-04-05",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05962788",
      "title": "Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE3",
      "condition": "Adolescent Lupus Nephritis, Pediatric Lupus Nephritis",
      "start_date": "2024-03-27",
      "completion_date": "2029-06",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05337124",
      "title": "A Prospective Observational Registry of Patients Treated With LUPKYNIS\u00ae (Voclosporin) in the US",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Lupus Nephritis",
      "start_date": "2022-04-05",
      "completion_date": "2025-01-31",
      "enrollment": 0,
      "sponsor": "Aurinia Pharmaceuticals Inc."
    }
  ],
  "summary": {
    "total_trials": 18,
    "by_phase": {
      "PHASE3": 8,
      "PHASE2, PHASE3": 1,
      "PHASE2": 6,
      "PHASE1": 2,
      "": 1
    },
    "by_status": {
      "WITHDRAWN": 1,
      "COMPLETED": 14,
      "TERMINATED": 1,
      "ENROLLING_BY_INVITATION": 1,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 14,
    "conditions": [
      "Adolescent Lupus Nephritis, Pediatric Lupus Nephritis",
      "Covid19, Kidney Transplant Infection",
      "Drug-drug Interaction",
      "Dry Eye",
      "Dry Eye Syndrome, Keratoconjunctivitis Sicca",
      "Focal Segmental Glomerulosclerosis",
      "Kidney Diseases",
      "Lupus Nephritis",
      "Psoriasis",
      "Renal Transplantation",
      "Volunteers"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:44.225453",
    "search_query": "Aurinia Pharmaceuticals Inc",
    "url": "https://clinicaltrials.gov/search?term=Aurinia+Pharmaceuticals+Inc"
  }
}